Chugai Pharmaceutical Future Growth

Future criteria checks 1/6

Chugai Pharmaceutical is forecast to grow earnings and revenue by 6.5% and 4.5% per annum respectively. EPS is expected to grow by 6.5% per annum. Return on equity is forecast to be 17.3% in 3 years.

Key information

6.5%

Earnings growth rate

6.5%

EPS growth rate

Pharmaceuticals earnings growth	19.6%
Revenue growth rate	4.5%
Future return on equity	17.3%
Analyst coverage	Good
Last updated	23 Sep 2024

Recent future growth updates

No updates

Recent updates

No updates

Earnings and Revenue Growth Forecasts

DB:CUP0 - Analysts future estimates and past financials data (JPY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	1,208,180	413,914	368,560	425,886	13
12/31/2025	1,151,434	382,910	345,315	407,900	15
12/31/2024	1,116,076	364,125	361,330	406,758	15
6/30/2024	1,084,570	355,041	265,465	327,068	N/A
3/31/2024	1,036,076	326,373	323,991	383,090	N/A
12/31/2023	1,111,367	325,472	350,827	409,925	N/A
9/30/2023	1,276,051	336,745	205,825	258,712	N/A
6/30/2023	1,243,437	326,969	200,169	252,605	N/A
3/31/2023	1,211,632	316,154	252,376	299,319	N/A
12/31/2022	1,259,946	374,429	172,873	244,112	N/A
9/30/2022	1,143,716	370,791	298,989	366,072	N/A
6/30/2022	1,205,696	389,011	339,236	422,551	N/A
3/31/2022	1,191,496	387,359	227,919	305,626	N/A
12/31/2021	999,759	302,995	206,760	279,626	N/A
9/30/2021	887,919	256,462	180,866	256,890	N/A
6/30/2021	809,055	230,577	194,361	252,664	N/A
3/31/2021	776,339	210,611	165,601	246,567	N/A
12/31/2020	786,946	214,733	143,646	205,035	N/A
9/30/2020	753,853	202,590	127,482	211,422	N/A
6/30/2020	734,019	190,599	108,080	196,718	N/A
3/31/2020	711,320	174,062	116,245	178,610	N/A
12/31/2019	686,184	157,560	145,464	206,641	N/A
9/30/2019	662,198	139,543	83,362	160,274	N/A
6/30/2019	614,949	113,070	43,280	118,955	N/A
3/31/2019	586,648	99,631	23,827	101,309	N/A
12/31/2018	579,787	92,488	41,403	119,074	N/A
9/30/2018	572,994	85,857	91,950	125,700	N/A
6/30/2018	566,548	85,285	84,103	120,997	N/A
3/31/2018	556,159	82,101	N/A	127,695	N/A
12/31/2017	534,199	72,713	N/A	107,623	N/A
9/30/2017	517,908	67,704	N/A	63,732	N/A
6/30/2017	497,023	58,143	N/A	67,355	N/A
3/31/2017	497,354	57,592	N/A	49,230	N/A
12/31/2016	491,780	53,592	N/A	38,787	N/A
9/30/2016	492,584	56,562	N/A	40,808	N/A
6/30/2016	506,192	62,537	N/A	39,670	N/A
3/31/2016	501,649	61,043	N/A	49,913	N/A
12/31/2015	498,839	61,125	N/A	62,918	N/A
9/30/2015	495,455	58,897	N/A	75,502	N/A
6/30/2015	479,265	52,220	N/A	50,719	N/A
3/31/2015	454,147	46,786	N/A	54,919	N/A
12/31/2014	461,109	50,980	N/A	37,034	N/A
9/30/2014	450,545	52,461	N/A	38,017	N/A
6/30/2014	444,658	55,044	N/A	60,556	N/A
3/31/2014	457,281	60,774	N/A	54,886	N/A
12/31/2013	423,652	50,895	N/A	53,521	N/A
9/30/2013	422,345	56,528	N/A	N/A	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CUP0's forecast earnings growth (6.5% per year) is above the savings rate (0.8%).

Earnings vs Market: CUP0's earnings (6.5% per year) are forecast to grow slower than the German market (20% per year).

High Growth Earnings: CUP0's earnings are forecast to grow, but not significantly.

Revenue vs Market: CUP0's revenue (4.5% per year) is forecast to grow slower than the German market (5.4% per year).

High Growth Revenue: CUP0's revenue (4.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: CUP0's Return on Equity is forecast to be low in 3 years time (17.3%).